C.R. Bard to shift jobs to NY; AngioDynamics wins CE mark for bypass device;

@FierceMedDev: Veracyte goes public, raises $65M and gains on Day 1. Article | Follow @FierceMedDev

@MarkHFierce: Carlos Slim backs more genomics and Dx work at the Broad Institute, and elsewhere, with a new infusion of $74M. FierceDiagnostics story | Follow @MarkHFierce

@MichaelGFierce: ICYMI - Editor's Corner: Nanotech promises new frontier as FDA decides how to regulate. More from FierceDrugDelivery | Follow @MichaelGFierce

> C.R. Bard ($BCR) plans to shift jobs to Queensburg, NY, after two rounds of layoffs last year. Story

> AngioDynamics ($ANGO) gained CE mark approval for its AngioVac venous drainage cannula and cardiopulmonary bypass circuit for extracorporeal bypass. Item

> SQI Diagnostics will work with Isis Pharmaceuticals ($ISIS) to develop an immunogenicity assay. Item

> Johns Hopkins University spinoff Hemova Medical, developer of a safer vascular access port for kidney dialysis, was among the top winners at this year's MassChallenge awards. Story

> CoActive Medical said it has been awarded a U.S. patent for technology that automatically transmits medical images, voice clips, reports and other patient details over the Internet to authorized users on their computers. Item

Biotech News

@FierceBiotech: Parexel's stock plunges despite spikes in revenue, profit. Report from FierceCRO | Follow @FierceBiotech

@JohnCFierce: Feds launch probe of AstraZeneca's controversial late-stage Brilinta study. Article | Follow @JohnCFierce

@DamianFierce: Do-it-all CRO inVentiv is buying Catalina Health to boost its patient adherence business. News | Follow @DamianFierce

@EmilyMFierce: New survey details impact of federal cuts, sequestration on scientific research. FierceBiotech Research story | Follow @EmilyMFierce

> Roche looks to trump GLP-1 diabetes drugs with a combo approach. More

> Ariad shares plunge again after FDA asks for a halt to Iclusig sales. Story

> Alzheimer's experts team up with Adimab, grab $10M to launch Alector. News

Pharma News

@FiercePharma: Biggest report yesterday: Top 10 Drug Patent Losses of 2014. Feature | Follow @FiercePharma

@CarlyHFierce: CEO Jeremy Levin steps down amid board squabble. Top story yesterday via FiercePharma | Follow @CarlyHFierce

> Who wants to step into Teva's CEO hot seat? Story

> Novo Nordisk recruiting 400 U.S. sales reps as growth decelerates. Article

Pharma Manufacturing News

@EricPFierce: Manufacturing, sanitation issues at Sanofi's Toronto vaccine plant has been a problem for some time now. Story | Follow @EricPFierce

> Foreign cancer-drug dealer gets prison. More

> Space issues lead GSK to close NJ facility, shift production. Report

> DSM opens Australia biologics plant. Story

> India renews duty on Chinese paracetamol. Article

Vaccines News

> Sanofi makes case for Fluzone superior clinical benefit label. News

> GSK, Sanofi join Gates Foundation vaccine R&D initiative. Report

> Vaccines a rare bright spot in Merck's gloomy financials. More

> ACIP recommendation gives Novartis a new growth opportunity. Story

> Dendreon reportedly seeking buyer for struggling business. Article

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.